Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8507-8515

  Huang, Margaret M ^a   Kew, Verity G ^a   Jestice, Kevin ^a   Wills, Mark R ^a   Reeves, Matthew B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LANGERIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; LANGERHANS CELL; LATENT VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS LATENCY; VIRUS REACTIVATION;

ANTIGENS, CD14; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; DENDRITIC CELLS; HUMANS; MONOCYTES; VIROLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84865066275     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00598-12     Document Type: Article

References (64)

1. Adler SP, Hur JK, Wang JB, Vetrovec GW. 1998. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J. Infect. Dis. 177:209-212.
2. + dendritic cells but not by Langerhans cells. Science 301:1925-1928.
3. Bechetoille N, Andre V, Valladeau J, Perrier E, Dezutter-Dambuyant C, Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli. J. Leukoc. Biol. 80:45-58.
4. +1 in Langerhans cell biology: the skin of transforming growth factor β1-null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184:2417-2422.
5. Bosnjak L, et al. 2005. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174:2220-2227.
6. Bursch LS, et al. 2007. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204:3147-3156.
7. Caposio P, Orloff SL, Streblow DN. 2011. The role of cytomegalovirus in angiogenesis. Virus Res. 157:204-211.
8. Carlier J, et al. 2011. Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells. Blood 118:6783-6792.
9. Caux C, et al. 1996. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184:695-706.
10. Clausen BE, Kel JM. 2010. Langerhans cells: critical regulators of skin immunity? Immunol. Cell Biol. 88:351-360.
11. Czernielewski JM, Demarchez M. 1987. Further evidence for the selfreproducing capacity of Langerhans cells in human skin. J. Invest. Dermatol. 88:17-20.
12. Danesh J, Collins R, Peto R. 1997. Chronic infections and coronary heart disease: is there a link? Lancet 350:430-436.
13. Dennler S, Goumans MJ, ten Dijke P. 2002. Transforming growth factor beta signal transduction. J. Leukoc. Biol. 71:731-740.
14. Geissmann F, et al. 1998. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187:961-966.
15. Ginhoux F, et al. 2007. Blood-derived dermal Langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204:3133-3146.
16. Goodrum F, Reeves M, Sinclair J, High K, Shenk T. 2007. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937-945.
17. Goodrum FD, Jordan CT, High K, Shenk T. 2002. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc. Natl. Acad. Sci. U. S. A. 99:16255-16260.
18. Grattan MT, et al. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566.
19. Hahn G, Jores R, Mocarski ES. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 95:3937-3942.
20. Hargett D, Shenk TE. 2010. Experimental human cytomegalovirus latency in CD14+ monocytes. Proc. Natl. Acad. Sci. U. S. A. 107:20039-20044.
21. He Y, Zhang J, Donahue C, and Falo LD, Jr. 2006. Skin-derived dendritic cells induce potent CD8+ T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24:643-656.
22. Hertel L, Lacaille VG, Strobl H, Mellins ED, Mocarski ES. 2003. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77:7563-7574.
23. Kanitakis J, Petruzzo P, Dubernard JM. 2004. Turnover of epidermal Langerhans' cells. N. Engl. J. Med. 351:2661-2662.
24. Kaplan DH. 2010. In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol. 31:446-451.
25. Kaplan DH, et al. 2007. Autocrine/paracrine TGF-β1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204:2545-2552.
26. Katz SI, Tamaki K, Sachs DH. 1979. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282:324-326.
27. Kondo K, Xu J, Mocarski ES. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. U. S. A. 93:11137-11142.
28. Lee AW, et al. 2006. Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J. Immunol. 177:3960-3971.
29. Lee AW, et al. 2011. Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol. Immunol. 48:1160-1167.
30. Legendre C, Pascual M. 2008. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences. Clin. Infect. Dis. 46:732-740.
31. Leruez-Ville M, et al. 2003. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J. Clin. Microbiol. 41:2040-2046.
32. Lutz MB, Rossner S. 2007. Factors influencing the generation of murine dendritic cells from bone marrow: the special role of fetal calf serum. Immunobiology 212:855-862.
33. MacAry PA, et al. 2001. Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. Proc. Natl. Acad. Sci. U. S. A. 98:3982-3987.
34. Mendelson M, Monard S, Sissons P, Sinclair J. 1996. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77(Pt 12):3099-3102.
35. Merad M, Ginhoux F, Collin M. 2008. Origin, homeostasis and function of Langerhans cells and other Langerin-expressing dendritic cells. Nat. Rev. Immunol. 8:935-947.
36. Merad M, et al. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3:1135-1141.
37. Minton EJ, Tysoe C, Sinclair JH, Sissons JG. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
38. Mitani H, et al. 2000. Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells. Br. J. Haematol. 109:288-295.
39. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocytederived dendritic cells. Blood 99:2913-2921.
40. Peggs KS, Mackinnon S. 2004. Cytomegalovirus: the role of CMV posthaematopoietic stem cell transplantation. Int. J. Biochem. Cell Biol. 36: 695-701.
41. Poole E, McGregor Dallas SR, Colston J, Joseph RS, Sinclair J. 2011. Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34 progenitors. J. Gen. Virol. 92:1539-1549.
42. Poulin LF, et al. 2007. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204:3119-3131.
43. Reeves MB, Compton T. 2011. Inhibition of inflammatory interleukin-6 activity via ERK-MAPK signaling antagonizes human cytomegalovirus reactivation from dendritic cells from latency. J. Virol. 85:12750-12758.
44. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH. 2005. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodeling. J. Gen. Virol. 86:2949-2954.
45. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. U. S. A. 102:4140-4145.
46. Reeves MB, Sinclair JH. 2010. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J. Gen. Virol. 91:599-604.
47. Riegler S, et al. 2000. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 81:393-399.
48. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
49. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3:1101-1108.
50. Schuler G, Steinman RM. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526-546.
51. Shklovskaya E, et al. 2011. Langerhans cells are precommitted to immune tolerance induction. Proc. Natl. Acad. Sci. U. S. A. 108:18049-18054.
52. Siena S, et al. 1995. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Exp. Hematol. 23:1463-1471.
53. Sindre H, et al. 1996. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 88:4526-4533.
54. Slobedman B, Mocarski ES. 1999. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73:4806-4812.
55. Slobedman B, et al. 2004. Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J. Virol. 78:4054-4062.
56. Soderberg-Naucler C, Fish KN, Nelson JA. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
57. Strobl H, et al. 1997. flt3 ligand in cooperation with transforming growth factor-β1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serumfree conditions. Blood 90:1425-1434.
58. Strunk D, et al. 1996. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 87: 1292-1302.
59. Taylor-Wiedeman J, Sissons P, Sinclair J. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
60. Torres-Madriz G, Boucher HW. 2008. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clin. Infect. Dis. 47:702-711.
61. Valladeau J, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71-81.
62. Vishwanath M, et al. 2006. Development of intravital intermittent confocal imaging system for studying Langerhans cell turnover. J. Invest. Dermatol. 126:2452-2457.
63. Zhu J, et al. 2001. Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response. Int. Immunol. 13:785-790.
64. Zhuravskaya T, et al. 1997. Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model ofHCMV latency. Blood 90:2482-2491.